Outcomes of Extracorporeal Membrane Oxygenation in Blood Culture Positive Septic Patients

C. Blazoski, Qiong Yang, H. Hirose
{"title":"Outcomes of Extracorporeal Membrane Oxygenation in Blood Culture Positive Septic Patients","authors":"C. Blazoski, Qiong Yang, H. Hirose","doi":"10.4236/wjcs.2020.108019","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: Extracorporeal membrane oxygenation (ECMO) is commonly used for \nrefractory cardiac or respiratory failure. There are reported cases of \nsuccessful use of ECMO in patients with septic shock; however, there is a lack \nof evidence to prove its overall efficacy. Thus, we conducted this study to \nanalyze the relationship between sepsis and ECMO in our own patients. METHODS: 305 patients who were placed on ECMO between 2010 and 2020 were identified \nwithin an IRB-approved database. Their clinical outcomes were analyzed with a specific focus on patients who were \nseptic before or during ECMO, defined as a positive blood culture. Group S was \ncomposed of patients with a positive blood culture before or during ECMO, while \nGroup N was composed of all patients without a positive blood culture before or \nduring ECMO. The primary outcome compared between groups was ECMO survival rate. RESULTS: Among the \n305 patients on ECMO, 58 (19%) were in Group S and 247 (81%) were in Group N. \nECMO survival rates were 45% in Group S and 62% in Group N (p = 0.017). CONCLUSION: Of our 305 patients, patients who were septic upon \nECMO placement or those who \ndeveloped sepsis during ECMO had worse ECMO survival rates than non-septic \npatients. Ultimately, patients who are septic or have a high probability of \nbecoming septic may not be indicated for ECMO placement, and cautious \nadministration of ECMO to these patients may be necessary.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"243 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Cardiovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/wjcs.2020.108019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

INTRODUCTION: Extracorporeal membrane oxygenation (ECMO) is commonly used for refractory cardiac or respiratory failure. There are reported cases of successful use of ECMO in patients with septic shock; however, there is a lack of evidence to prove its overall efficacy. Thus, we conducted this study to analyze the relationship between sepsis and ECMO in our own patients. METHODS: 305 patients who were placed on ECMO between 2010 and 2020 were identified within an IRB-approved database. Their clinical outcomes were analyzed with a specific focus on patients who were septic before or during ECMO, defined as a positive blood culture. Group S was composed of patients with a positive blood culture before or during ECMO, while Group N was composed of all patients without a positive blood culture before or during ECMO. The primary outcome compared between groups was ECMO survival rate. RESULTS: Among the 305 patients on ECMO, 58 (19%) were in Group S and 247 (81%) were in Group N. ECMO survival rates were 45% in Group S and 62% in Group N (p = 0.017). CONCLUSION: Of our 305 patients, patients who were septic upon ECMO placement or those who developed sepsis during ECMO had worse ECMO survival rates than non-septic patients. Ultimately, patients who are septic or have a high probability of becoming septic may not be indicated for ECMO placement, and cautious administration of ECMO to these patients may be necessary.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血培养阳性脓毒症患者体外膜氧合的疗效
体外膜氧合(ECMO)常用于治疗难治性心脏或呼吸衰竭。有报道称,在脓毒性休克患者中成功使用ECMO;然而,缺乏证据证明其整体功效。因此,我们进行了这项研究,以分析我们自己的患者脓毒症与ECMO的关系。方法:在2010年至2020年期间,在irb批准的数据库中确定了305名接受ECMO的患者。他们的临床结果被分析,特别关注在ECMO之前或期间败血症的患者,定义为阳性血培养。S组由ECMO前或ECMO期间血培养阳性的患者组成,N组由ECMO前或ECMO期间血培养未阳性的患者组成。各组间比较的主要转归为ECMO生存率。结果:305例ECMO患者中,S组58例(19%),N组247例(81%),S组ECMO生存率为45%,N组为62% (p = 0.017)。结论:在我们的305例患者中,在ECMO放置时脓毒症患者或在ECMO期间发生脓毒症的患者的ECMO生存率低于非脓毒症患者。最终,脓毒性或脓毒性高的患者可能不适合放置ECMO,对这些患者谨慎使用ECMO可能是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Acute Myocardial Infarction: Mode of Revelation of a Left Atrium Myxoma Cardiac Manifestations with Chemotherapeutic Agents: 5 Fluorouracil-Induced Coronary Artery Vasospasm Microbiological and Antibiotic Susceptibility Patterns in Cardiothoracic and Vascular Intensive Care Unit of a Tertiary Level Hospital in Nepal Cardiovascular Function during First 24 Hours after Off-Pump and On-Pump CABG—A Prospective Observational Comparative Study Is Anticoagulation Warranted after Left Atrial Appendage Ligation in Patients at Risk for Stroke after Cardiac Surgery?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1